Treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients in Eastern Ethiopia: a retrospective study
- PMID: 30167059
- PMCID: PMC6110564
- DOI: 10.11604/pamj.2018.30.32.12554
Treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients in Eastern Ethiopia: a retrospective study
Abstract
Introduction: Tuberculosis is the leading cause of morbidity and mortality among people living with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome worldwide. Although Human Immunodeficiency Virus related tuberculosis is both treatable and preventable, incidence rates continue to climb in developing countries where both infections are endemic. The aim of this study was to assess the treatment outcome of tuberculosis among Human Immunodeficiency Virus positive patients attending in three hospitals of Eastern Ethiopia.
Methods: A retrospective clinical record review was conducted for 627 Tuberculosis and Human immunodeficiency virus co-infected patients registered from January 2008 to January 2014 cards were reviewed in three hospitals of tuberculosis clinics of Eastern Ethiopia from December 2015 to February 2016. The three hospitals were selected based on their high patient load of TB-HIV co infection and the presence of ART and TB units. Data on patient's details and tuberculosis treatment outcome were collected using standardized report format of National Tuberculosis and Leprosy Control Programme (NTLCP). The collected data were analyzed by Statistical Package for Social Sciences (SPSS) software Version 16.
Results: The overall treatment success rate was 78.3%. Of the total TB-HIV co infected study participants, 17.9% cured, 60.4% treatment completed, 8.6% died, 0.6% failure, 1.8% defaulter and 10.7% transferred out. Those participants in the age groups of less than or equals to 18 years old (Adjusted Odds Ratio = 1.990, 95% Confidence Interval: 1.01, 3.350), extra pulmonary tuberculosis (Adjusted Odds Ratio = 1.51, 95% Confidence Interval = 1.12, 3.42), on antiretro viral therapy (Adjusted Odds Ratio = 1.54, 95% Confidence Interval = 1.252, 3.910) were more likely to have higher treatment outcome than each of the above variables counter parts.
Conclusion: The rate of treatment success in this study was lower than recommended rate by World Health Organization. Thus this study recommends improving counseling during tuberculosis treatment, providing home visits and motivation of patients, improving defaulter tracing and health information dissemination in order to reduce treatment interruption.
Keywords: Eastern Ethiopia; Human Immunodeficiency Virus; Tuberculosis; defaulter; died; failure; transferred out; treatment success.
References
-
- AIDS Control and Prevention (AIDSCAP) Project of Family Health Internal, the Francois-Xavier Bagnoud Center for Public Health and Human Rights of the Harvard School of Public Health, UNAIDS. The Status and Trends of the Global HIV/AIDS Pandemic; 1996.
-
- Federal HIV/AIDS Prevention and Control Office: Federal Ministry of Health (FMOH) Guidelines for management of Opportunistic Infections and Anti-Retroviral Treatment in Adolescents and Adults in Ethiopia. 2008.
-
- World Health Organization . Global tuberculosis control. 20th edition. Geneva: World Health Organization; 2015. WHO report.
-
- World Health Organization . Global tuberculosis control: Surveillance, planning and financing: WHO report. WHO/HTM/TB/2008.393. Geneva: World Health Organization; 2008.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical